Please login to bookmark Close
IP Australia handed a win Thursday to a company challenging a Bayer animal drug patent, but gave Bayer an additional two months to address its concerns about the patent application’s deficiencies.
Commonwealth Bank denies Austrac money laundering claims
Please login to bookmark Close
The Commonwealth Bank of Australia on Friday pushed back against the majority of expanded claims brought by the anti-money laundering regulator and denied all allegations in the related class action.
Ex-Charter Financial adviser banned for fleecing elderly clients
Please login to bookmark Close
A former financial adviser for Charter Financial Planning has been permanently barred from providing financial advice by Australia’s corporate regulator after it found he deducted almost $67,000 in fees for advice he never gave.
Linfox workers can’t halt Fair Work case, court says
Please login to bookmark Close
A group of Linfox workers in Victoria has lost their bid to put a Fair Work appeal on ice while they challenge a commissioner’s ruling that found in favor of the logistics giant in a dispute over their jobs.
Judge in sports betting class action won’t recuse himself
Please login to bookmark Close
A judge overseeing a class action brought by investors in a sports betting scheme has shot down a lawyer’s mid-trial bid that he recuse himself.
Google bid for ad patent shot down by IP Australia
Please login to bookmark Close
IP Australia has denied Google’s application for approval of a patent covering advertising price discounting, saying it was not a manner of manufacture and therefore not patentable.
Norton Rose dispute with ex-partner heads to mediation
Please login to bookmark Close
A bitter court battle over the firing of a Norton Rose Fulbright employment partner in which the firm admitted it retroactively signed and dated a court document will soon head to mediation.
Sanofi wins challenge to Reckitt-Benckiser lozenge patent
Please login to bookmark Close
The Australian Patent Office has shot down a patent application covering throat lozenges by consumer goods giant Reckitt-Benckiser on a challenge by rival Sanofi-Aventis.
GetSwift hit with $300M shareholder class action
Please login to bookmark Close
Squire Patton Boggs has brought a shareholder class action worth potentially $300 million against logistics software company GetSwift and its director, former AFL player Joel MacDonald, for providing inadequate disclosures and misleading investors with “overhyped” announcements about business contracts.
Slater & Gordon slams letter in union merger bid
Please login to bookmark Close
A Slater and Gordon lawyer representing three unions seeking Fair Work Commission approval for a proposed tie-up, has slammed an “urgent” email from counsel at Herbert Smith Freehills claiming a newly discovered contempt matter involving one of the deal’s applicants should bar approval of the deal.